CellGenix -Model GMP DC -Medium Dendritic Cell
CellGenix GMP DC is an optimized, serum-free medium used for the generation of human dendritic cells (DCs). It promotes high yields of mature dendritic cells with the desired phenotype.
General Information
CellGenix® GMP DC is optimized for the differentiation of CD14+ monocytes into mature DCs. It is used for the generation of dendritic cell therapies, which represent a new and promising immunotherapeutic approach for treatment of different types of cancer.
We offer the cytokines and growth-factors needed for optimal growth separately. This gives you the freedom to customize and create your own optimal cytokine mixture. To fit different cell and gene therapy manufacturing processes, we conveniently offer our media in both bags and in bottles.
GMP grade
CellGenix® GMP DC is produced following all applicable GMP guidelines and allows for the safe use in accordance with USP Chapterand ISO Technical Standard 20399:2022. Our GMP Media are provided with documented evidence of sterility, activity and stability. In combination with our expert regulatory and technical support this will help simplify your raw material qualification and validation efforts.
- Serum-free cell culture conditions
- Optimized formulation for the generation of DCs
- FDA Drug Master File available (on request)
- Compliant to USP Chapter
- Differentiation of CD14+ monocytes into DCs
- Differentiation of CD14+ monocytes into macrophages
CellGenix® GMP Quality Standard
- High lot-to-lot consistency – save time and costs on revalidations
- Defined media formulation – rely on consistent product performance
- Batch-to-batch quality control – ensure the safety of your ATMP
- Expert regulatory & technical support – rely on experience
Read more about our GMP Quality